202 related articles for article (PubMed ID: 16714328)
1. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.
Tonelli M; Jose P; Curhan G; Sacks F; Braunwald E; Pfeffer M;
BMJ; 2006 Jun; 332(7555):1426. PubMed ID: 16714328
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
3. The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients.
Moukarbel GV; Yu ZF; Dickstein K; Hou YR; Wittes JT; McMurray JJ; Pitt B; Zannad F; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2014 Mar; 16(3):289-99. PubMed ID: 24464979
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
Lambert ND; Sacrinty MT; Ketch TR; Turner SJ; Santos RM; Daniel KR; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2009 Apr; 157(4):688-94. PubMed ID: 19332197
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan.
Nagata M; Ninomiya T; Kiyohara Y; Murakami Y; Irie F; Sairenchi T; Miura K; Okamura T; Ueshima H;
Am J Epidemiol; 2013 Jul; 178(1):1-11. PubMed ID: 23752917
[TBL] [Abstract][Full Text] [Related]
6. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.
Oh SW; Baek SH; Kim YC; Goo HS; Heo NJ; Na KY; Chae DW; Kim S; Chin HJ
Nephrol Dial Transplant; 2012 Jun; 27(6):2284-90. PubMed ID: 22140122
[TBL] [Abstract][Full Text] [Related]
7. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).
Mercado N; Brugts JJ; Ix JH; Shlipak MG; Dixon SR; Gersh BJ; Lemos PA; Guarneri M; Teirstein PS; Wijns W; Serruys PW; Boersma E; O'Neill WW
Am J Cardiol; 2008 Nov; 102(9):1151-5. PubMed ID: 18940282
[TBL] [Abstract][Full Text] [Related]
9. Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Peters R; Beckett N; Poulter R; Burch L; Narkiewicz K; Fagard R; Nitsch D; Wang N; Li M; Fletcher A; Bulpitt C
Age Ageing; 2013 Mar; 42(2):253-8. PubMed ID: 22910302
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Pfeffer MA; Burdmann EA; Chen CY; Cooper ME; de Zeeuw D; Eckardt KU; Ivanovich P; Kewalramani R; Levey AS; Lewis EF; McGill J; McMurray JJ; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto R; Uno H;
Am J Kidney Dis; 2009 Jul; 54(1):59-69. PubMed ID: 19501439
[TBL] [Abstract][Full Text] [Related]
11. Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study.
Zambon S; Maggi S; Zanoni S; Romanato G; Noale M; Corti MC; Sartori L; Musacchio E; Baggio G; Sergi G; Crepaldi G; Manzato E
Atherosclerosis; 2012 Jan; 220(1):201-7. PubMed ID: 22018644
[TBL] [Abstract][Full Text] [Related]
12. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
13. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
14. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria.
Tonelli M; Klarenbach SW; Lloyd AM; James MT; Bello AK; Manns BJ; Hemmelgarn BR
Kidney Int; 2011 Dec; 80(12):1306-14. PubMed ID: 21849971
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
[TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
[TBL] [Abstract][Full Text] [Related]
17. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
Tonelli M; Sacks F; Pfeffer M; Gao Z; Curhan G;
Circulation; 2005 Oct; 112(17):2627-33. PubMed ID: 16246962
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
[TBL] [Abstract][Full Text] [Related]
20. Impaired renal function in acute myocardial infarction.
Lekston A; Kurek A; Tynior B
Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
